Cells cancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells Cell Line HT29 Cells Neoplastic Stem Cells HeLa Cells

Organisms5

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae

Diseases50

Neoplasms Kidney Neoplasms Carcinoma, Renal Cell Radiation Injuries Carcinoma, Squamous Cell Breast Neoplasms Testicular Neoplasms Neoplasms, Squamous Cell Lung Neoplasms Neoplasms, Germ Cell and Embryonal Head and Neck Neoplasms Colonic Neoplasms Neoplasm Metastasis Leiomyomatosis Ovarian Neoplasms Prostatic Neoplasms Germinoma Neoplasms, Radiation-Induced Neoplasm Invasiveness Pancreatic Neoplasms Stomach Neoplasms Esophageal Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Radiation Injuries, Experimental Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Cell Transformation, Neoplastic Radiation Pneumonitis Neoplasm Recurrence, Local Skin Neoplasms Disease Progression Neoplasms, Experimental Carcinoma Seminoma Melanoma Liver Neoplasms Genetic Predisposition to Disease Mouth Neoplasms Brain Neoplasms Colorectal Neoplasms Carcinoma, Small Cell Oropharyngeal Neoplasms Neoplasms, Second Primary Carcinoma, Transitional Cell Anus Neoplasms Mammary Neoplasms, Experimental Rectal Neoplasms Neoplastic Syndromes, Hereditary

Chemicals and Drugs74

Antineoplastic Agents Cisplatin Antineoplastic Agents, Phytogenic Doxorubicin Antibiotics, Antineoplastic Neoplasm Proteins Fumarate Hydratase Tumor Suppressor Protein p53 Paclitaxel Etoposide Drug Carriers Fluorouracil Radiation-Sensitizing Agents Tumor Markers, Biological Cancer Vaccines RNA, Small Interfering Camptothecin RNA, Messenger Bleomycin Enzyme Inhibitors Antibodies, Monoclonal DNA, Neoplasm Protein Kinase Inhibitors Antimetabolites, Antineoplastic P-Glycoprotein Ellipticines Indoles Proto-Oncogene Proteins c-bcl-2 Receptor, Epidermal Growth Factor Antigens, Neoplasm Angiogenesis Inhibitors Tumor Suppressor Proteins Anticarcinogenic Agents Taxoids Caspases Deoxycytidine Pyrroles Plant Extracts Vinblastine DNA-Binding Proteins Receptor, erbB-2 Organoplatinum Compounds Caspase 3 Prodrugs TOR Serine-Threonine Kinases DNA Protein-Serine-Threonine Kinases Nanocapsules Platinum Radiation-Protective Agents Topoisomerase I Inhibitors Proto-Oncogene Proteins c-akt Antibodies, Monoclonal, Humanized Nuclear Proteins Antineoplastic Agents, Alkylating Phenylurea Compounds Niacinamide Histone Deacetylase Inhibitors Benzenesulfonates Daunorubicin DNA Topoisomerases, Type II Apoptosis Regulatory Proteins RNA, Neoplasm Tamoxifen Drugs, Investigational Receptors, Estrogen Carboplatin Proto-Oncogene Proteins Reactive Oxygen Species Cell Cycle Proteins Prostate-Specific Antigen Poly(ADP-ribose) Polymerases Quinazolines Mitomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Early Detection of Cancer Molecular Targeted Therapy Radiotherapy Neoplasm Transplantation Drug Carriers Prognosis Clinical Trials as Topic Treatment Outcome Blotting, Western Survival Rate Survival Analysis Neoplasm Staging Tumor Burden Radiotherapy Dosage Reverse Transcriptase Polymerase Chain Reaction Disease-Free Survival Drug Design Radiation Injuries, Experimental Transplantation, Heterologous Models, Biological Inhibitory Concentration 50 Retrospective Studies Follow-Up Studies Neoplasms, Experimental Gene Expression Profiling Risk Factors Flow Cytometry Radiometry Immunotherapy Transfection Prospective Studies Risk Immunohistochemistry Chemotherapy, Adjuvant Drug Evaluation, Preclinical Drug Administration Schedule Risk Assessment Radiotherapy, Adjuvant Genetic Therapy Drug Discovery Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Registries Nanocapsules Tomography, X-Ray Computed Hyperthermia, Induced Sensitivity and Specificity Polymerase Chain Reaction Incidence Gene Knockdown Techniques Mammary Neoplasms, Experimental Multivariate Analysis Odds Ratio Reproducibility of Results Tumor Stem Cell Assay Clinical Trials, Phase I as Topic Positron-Emission Tomography

Psychiatry and Psychology1

Phenomena and Processes50

Radiation, Ionizing Radiation Dosage Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Drug Resistance, Neoplasm Radiation Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation DNA Damage Dose-Response Relationship, Drug Cell Cycle Signal Transduction Gamma Rays Cosmic Radiation Mutation Drug Synergism Time Factors Cell Division Inhibitory Concentration 50 Down-Regulation Drug Resistance, Multiple DNA Repair Ultraviolet Rays Transfection Background Radiation Genetic Predisposition to Disease Risk Molecular Structure Up-Regulation RNA Interference Cell Death Genes, p53 Cell Growth Processes Base Sequence Phosphorylation Gene Silencing Radiation Effects DNA Methylation Gene Expression Cell Movement Sensitivity and Specificity Phenotype Odds Ratio Promoter Regions, Genetic Enzyme Activation X-Rays Protein Binding Polymorphism, Genetic

Disciplines and Occupations6

Radiation Oncology Drug Design Nanomedicine Medical Oncology Immunohistochemistry Drug Discovery

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Architecture as Topic Nanocapsules

Information Science5

Survival Rate Molecular Sequence Data Base Sequence Registries Incidence

Named Groups1

Health Care30

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Clinical Trials as Topic Treatment Outcome Survival Rate Survival Analysis Cosmic Radiation Disease-Free Survival Radiation Injuries, Experimental Retrospective Studies Follow-Up Studies Risk Factors National Cancer Institute (U.S.)Ultraviolet Rays Prospective Studies Risk Risk Assessment Radiation Effects Kaplan-Meier Estimate Registries Age Factors Sensitivity and Specificity Incidence Multivariate Analysis Odds Ratio Reproducibility of Results Clinical Trials, Phase I as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Radiation, Ionizing Radiation Dosage Kidney Neoplasms Carcinoma, Renal Cell Cell Line, Tumor Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Drug Screening Assays, Antitumor Apoptosis Drug Resistance, Neoplasm Carcinoma, Squamous Cell Mice, Nude Cisplatin Radiation Xenograft Model Antitumor Assays Breast Neoplasms Cell Survival Radiation Protection Testicular Neoplasms Neoplasms, Squamous Cell Drug Delivery Systems Radiation Monitoring Gene Expression Regulation, Neoplastic Lung Neoplasms Antineoplastic Agents, Phytogenic Tumor Cells, Cultured Combined Modality Therapy Neoplasms, Germ Cell and Embryonal Cell Proliferation Head and Neck Neoplasms Doxorubicin Antineoplastic Combined Chemotherapy Protocols Colonic Neoplasms Neoplasm Metastasis Leiomyomatosis Ovarian Neoplasms Antibiotics, Antineoplastic Prostatic Neoplasms Early Detection of Cancer Radiation Oncology Neoplasm Proteins Molecular Targeted Therapy Radiotherapy Fumarate Hydratase DNA Damage Tumor Suppressor Protein p53 Neoplasm Transplantation Dose-Response Relationship, Drug Paclitaxel Etoposide Drug Carriers Prognosis Germinoma Cell Cycle Neoplasms, Radiation-Induced Neoplasm Invasiveness Signal Transduction Fluorouracil Gamma Rays Radiation-Sensitizing Agents Clinical Trials as Topic Tumor Markers, Biological Treatment Outcome Blotting, Western Survival Rate Pancreatic Neoplasms Cancer Vaccines Survival Analysis Neoplasm Staging RNA, Small Interfering Tumor Burden Stomach Neoplasms Radiotherapy Dosage Cosmic Radiation Mutation Reverse Transcriptase Polymerase Chain Reaction Esophageal Neoplasms Uterine Cervical Neoplasms Drug Synergism Camptothecin RNA, Messenger Bleomycin Disease-Free Survival Time Factors Adenocarcinoma Cell Division Drug Design Nanoparticles Radiation Injuries, Experimental Urinary Bladder Neoplasms Transplantation, Heterologous Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Models, Biological Inhibitory Concentration 50 Enzyme Inhibitors Nanomedicine

No FAQ available that match "cells cancer therapy anticancer drugs or radiation"